Bibliography
- Landgraf P , SiegF, MeyerG, WahleP, KreutzMR, PapeHC: A maternal blood-borne factor promotes survival of the developing thalamus.FASEB J.19, 225–227 (2005).
- Landgraf P , WahleP, PapeHC, GundelfingerED, KreutzMR: The survival promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity.J. Biol. Chem.283, 25036–25045 (2008).
- Obst K , WahleP: Phenotype specification of cortical neurons during a period of molecular plasticity.Eur. J. Neurosci.9, 2571–2580 (1997).
- Schittek B , HipfelR, SauerBet al.: Dermcidin: a novel human antibiotic peptide secreted by sweat glands.Nat. Immunol.2, 1133–1137 (2001).
- Rieg S , SeeberS, SteffenHet al.: Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites.J. Invest. Dermatol.126, 354–365 (2006).
- Stewart GD , SkipworthRJ, PenningtonCJet al.: Variation in dermcidin expression in a range of primary human tumors and in hypoxic/oxidatively stressed human cell lines.Br. J. Cancer99, 126–132 (2008)
- Todorov P , CariukP, McDevittT, ColesB, FearonK, TisdaleM : Characterization of a cancer cachectic factor. Nature379, 739–742 (1996).
- Tisdale MJ : Cachexia in cancer patients.Nat. Rev. Cancer2, 862–871 (2002).
- Porter D , WeremowiczS, ChinKet al.: A neural survival factor is a candidate oncogene in breast cancer.Proc. Natl Acad. Sci. USA100, 10931–10936 (2003).
- Watchorn TM , WaddellI, RossJA: Proteolysis-inducing factor differentially influences transcriptional regulation in edothelial subtypes.Am. J. Physiol. Endocrinol. Metab.282, E763–E769 (2002).
- Cunningham TJ , HodgeL, SpeicherDet al.: Identification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin.J. Neurosci.18, 7047–7060 (1998).
- Cunningham TJ , JingH, AkerblomI, MorganR, FisherTS, NeveuM: Identification of the human cDNA for new survival/evasion peptide (DSEP): studies in vitro and in vivo of overexpression by neural cells.Exp. Neurol.177, 32–39 (2002).
- Cunningham TJ , JingH, WangY, HodgeL: Calreticulin binding and other biological activities of survival peptide Y-P30 including effects of systemic treatment of rats.Exp. Neurol.163, 457–468 (2000).
- Naegele JR , BarnstableCJ, WahleP: Expression of a unique 56-kDa polypeptide in the subplate zone of the developing cerebral cortex.Proc. Natl Acad. Sci. USA88, 330–334 (1991).
- Henschel R , WahleP: The SP1 antigen in subplate neurons of the developing cat cortex is an immunoglobulin-like molecule.Eur. J. Neurosci.6, 1239–1246 (1994).
- Weiner JA , ChunJ: Maternally derived immunoglobulin light chain is present in the fetal mammalian CNS.J. Neurosci.17, 3148–3156 (1997).
- Rauvala H , HuttunenHJ, FagesCet al.: Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility.Matrix Biol.19, 377–387 (2000).
- Kinnunen A , NiemiM, KinnunenT, KaksonenM, NoloR, RauvalaH: Heparan sulphate and HB-GAM (heparin-binding growth-associated molecule) in the development of the thalamocortical pathway of rat brain.Eur. J. Neurosci.11, 491–502 (1999).
- Kinnunen A , KinnunenT, KaksonenM, NoloR, PanulaP, RauvalaH: N-syndecan and HB-GAM (heparin-binding growth-associated molecule) associate with early axonal tracts in the rat brain.Eur. J. Neurosci.10, 635–648 (1998).
- Kinnunen T , RauloE, NoloR, MaccaranaM, LindahlU, RauvalaH: Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface.J. Biol. Chem.271, 2243–2248 (1996).
- Kinnunen T , KaksonenM, SaarinenJ, KalkkinenN, PengHB, RauvalaH: Cortactin–Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth.J. Biol. Chem.273, 10702–10708 (1998).
- Perez-Pinera P , ChangY, DeuelTF: Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts.Cell Cycle6, 2877–2883 (2007).
- Perez-Pinera P , ZhangW, ChangY, VegaJA, DeuelTF: Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase β/ζ signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.J. Biol. Chem.282, 28683–28690 (2007).
- Chang Y , ZukaM, Perez-PineraPet al.: Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment.Proc. Natl Acad. Sci. USA104, 10888–10893 (2007).
- Herling S , JünglingK, LandgrafPet al.: The role of the survival promoting peptide, SPP/Y-P30 in differentiation of stem cell-derived neurons. Program and Abstracts of the 5th Forum of the Federation of European Neuroscience Societies (FENS). Vienna, Austria (2006) ( Abstract A228.7).
- Wagh S , Grote-WestrickC, LandgrafP, KreutzMR, PapeHC, WahleP: Survival promoting peptide (SPP) promotes axonal growth and enhances cell migration, but retards somatodendritic differentiation. Program and Abstracts of the 5th Forum of the Federation of European Neuroscience Societies (FENS). Vienna, Austria (2006) (Abstract A122.22).
- Dash-Wagh S , LandgrafP, KreutzMR, PapeHC, WahleP : Survival promoting peptide/ Y-P30 differentially effects the growth of axons and dendrites. Program and Abstracts of the 6th Forum of the Federation of European Neuroscience Societies (FENS). Geneva, Switzerland (2008) (Abstract A042.10).
- Iseki K , HaginoS, MoriTet al.: Increased syndecan expression by pleiotrophin and FGF receptor-expressing astrocytes in injured brain tissue.Glia39, 1–9 (2002).